GBD 2017 Inflammatory Bowel Disease Collaborators. (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology and Hepatology, 5(1), 17–30.

Article  Google Scholar 

Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019). ACG clinical guideline: Ulcerative colitis in adults. American Journal of Gastroenterology, 114(3), 384–413.

Article  PubMed  Google Scholar 

US Food and Drug Administration (FDA). (2022). Ulcerative colitis: Developing drugs for treatment. Guidance for industry (draft guidance). Retrieved May 9, 2023, from https://www.fda.gov/media/158016/download

Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., Schölmerich, J., Bemelman, W., Danese, S., Mary, J. Y., Rubin, D., Colombel, J. F., Peyrin-Biroulet, L., Dotan, I., Abreu, M. T., & Dignass, A. (2021). STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology, 160(5), 1570–1583.

Article  PubMed  CAS  Google Scholar 

Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., de Villiers, W. J. S., Present, D., Sands, B. E., & Colombel, J. F. (2005). Infliximab for induction and maintenance therapy for ulcerative colitis. The New England Journal of Medicine, 353(23), 2462–2476.

Article  PubMed  CAS  Google Scholar 

Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J. F., Sandborn, W. J., Van, A. G., Axler, J., Kim, H. J., Danese, S., Fox, I., Milch, C., Sankoh, S., Wyant, T., Xu, J., & Parikh, A. (2013). Vedolizumab as induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine, 369(8), 699–710.

Article  PubMed  CAS  Google Scholar 

Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., Friedman, G., Lawendy, N., Yu, D., Woodworth, D., Mukherjee, A., Zhang, H., Healey, P., & Panés, J. (2017). Tofacitinib as induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine, 376(18), 1723–1736.

Article  PubMed  CAS  Google Scholar 

Sands, B. E., Sandborn, W. J., Panaccione, R., O’Brien, C. D., Zhang, H., Johanns, J., Adedokun, O. J., Li, K., Peyrin-Biroulet, L., Van, A. G., Danese, S., Targan, S., Abreu, M. T., Hisamatsu, T., Szapary, P., & Marano, C. (2019). Ustekinumab as induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine, 381(13), 1201–1214.

Article  PubMed  CAS  Google Scholar 

Santiago, P., Braga-Neto, M. B., & Loftus, E. V. (2022). Novel therapies for patients with inflammatory bowel disease. Gastroenterology & Hepatology (New York), 18(8), 453–465.

Google Scholar 

US Food and Drug Administration (FDA). (2022). Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for industry. Food and Drug Administration staff, and other stakeholders. Draft guidance. Retrieved May 9, 2023, from https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-focused-drug-development-selecting-developing-or-modifying-fit-purpose-clinical-outcome

European Medicines Agency (EMA). (2018). Guideline on the development of new medicinal products for the treatment of ulcerative colitis. Retrieved May 9, 2023, from https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-development-new-medicinal-products-treatment-ulcerative-colitis-revision-1_en.pdf

Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65.

Article  PubMed  CAS  Google Scholar 

Guest, G., MacQueen, K. M., & Namey, E. E. (2011). Applied thematic analysis. Sage.

Google Scholar 

US Food and Drug Administration (FDA). (2009). Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Retrieved May 9, 2023, from https://www.fda.gov/media/77832/download

Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., Bouter, L. M., & de Vet, H. C. (2010). The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality of Life Research, 19(4), 539–549.

Article  PubMed  PubMed Central  Google Scholar 

Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., Bouter, L. M., & de Vet, H. C. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology, 63(7), 737–745.

Article  PubMed  Google Scholar 

Terwee, C. B., Mokkink, L. B., Knol, D. L., Ostelo, R. W., Bouter, L. M., & de Vet, H. C. (2012). Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Quality of Life Research, 21(4), 651–657.

Article  PubMed  Google Scholar 

Terwee, C. B., Prinsen, C. A. C., Chiarotto, A., Westerman, M. J., Patrick, D. L., Alonso, J., Bouter, L. M., de Vet, H. C. W., & Mokkink, L. B. (2018). COSMIN methodology for evaluating the content validity of patient-reported outcome measures: A Delphi study. Quality of Life Research, 27(5), 1159–1170.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Barberio, B., Zamani, M., Black, C. J., Savarino, E. V., & Ford, A. C. (2021). Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology, 6(5), 359–370.

Article  PubMed  Google Scholar 

Byron, C., Cornally, N., Burton, A., & Savage, E. (2020). Challenges of living with and managing inflammatory bowel disease: A meta-synthesis of patients’ experiences. Journal of Clinical Nursing, 29(3–4), 305–319.

Article  PubMed  Google Scholar 

Calvet, X., Arg✓elles-Arias, F., López-Sanromán, A., Cea-Calvo, L., Juliá, B., de Santos, C. R., & Carpio, D. (2018). Patients’ perceptions of the impact of ulcerative colitis on social and professional life: Results from the UC-LIFE survey of outpatient clinics in Spain. Patient Preference and Adherence, 12, 1815–1823.

Article  PubMed  PubMed Central  Google Scholar 

Carpio, D., López-Sanromán, A., Calvet, X., Romero, C., Cea-Calvo, L., Juliá, B., & Arg✓elles-Arias, F. (2016). Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey. European Journal of Gastroenterology and Hepatology, 28(9), 1056–1064.

Article  PubMed  Google Scholar 

Chan, W., Shim, H. H., Lim, M. S., Sawadjaan, F. L. B., Isaac, S. P., Chuah, S. W., Leong, R., & Kong, C. (2017). Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability. Digestive and Liver Disease, 49(12), 1314–1319.

Article  PubMed  Google Scholar 

Dubinsky, M. C., Watanabe, K., Molander, P., Peyrin-Biroulet, L., Rubin, M., Melmed, G. Y., Deuring, J. J., Woolcott, J., Cappelleri, J. C., Steinberg, K., & Connor, S. (2021). Ulcerative colitis narrative global survey findings: The impact of living with ulcerative colitis—patients’ and physicians’ view. Inflammatory Bowel Diseases, 27(11), 1747–1755.

Article  PubMed  PubMed Central  Google Scholar 

Dulai, P. S., Jairath, V., Khanna, R., Ma, C., McCarrier, K. P., Martin, M. L., Parker, C. E., Morris, J., Feagan, B. G., & Sandborn, W. J. (2020). Development of the symptoms and impacts questionnaire for Crohn’s disease and ulcerative colitis. Alimentary Pharmacology & Therapeutics, 51(11), 1047–1066.

Article  Google Scholar 

Eluri, S., Cross, R. K., Martin, C., Weinfurt, K. P., Flynn, K. E., Long, M. D., Chen, W., Anton, K., Sandler, R. S., & Kappelman, M. D. (2018). Inflammatory bowel diseases can adversely impact domains of sexual function such as satisfaction with sex life. Digestive Diseases and Sciences, 63(6), 1572–1582.

Article  PubMed  PubMed Central  Google Scholar 

Fourie, S., Jackson, D., & Aveyard, H. (2018). Living with inflammatory bowel disease: A review of qualitative research studies. International Journal of Nursing Studies, 87, 149–156.

Article  PubMed  Google Scholar 

García-Alanís, M., Quiroz-Casian, L., Castañeda-González, H., Arguelles-Castro, P., Toapanta-Yanchapaxi, L., Chiquete-Anaya, E., Sarmiento-Aguilar, A., Bozada-Gutiérrez, K., & Yamamoto-Furusho, J. K. (2021). Prevalence of mental disorder and impact on quality of life in inflammatory bowel disease. Gastroenterologia y Hepatologia, 44(3), 206–213.

Article  PubMed  Google Scholar 

Ghosh, S., Sanchez Gonzalez, Y., Zhou, W., Clark, R., Xie, W., Louis, E., Loftus, E. V., Panes, J., & Danese, S. (2021). Upadacitinib treatment improves symptoms of bowel urgency and abdominal pain, and correlates with quality of life improvements in patients with moderate to severe ulcerative colitis. Journal of Crohn’s & Colitis, 15(12), 2022–2030.

Article  Google Scholar 

Hashash, J. G., Ramos-Rivers, C., Youk, A., Chiu, W. K., Duff, K., Regueiro, M., Binion, D. G., Koutroubakis, I., Vachon, A., Benhayon, D., Dunn, M. A., & Szigethy, E. M. (2018). Quality of sleep and coexistent psychopathology have significant impact on fatigue burden in patients with inflammatory bowel disease. Journal of Clinical Gastroenterology, 52(5), 423–430.

Article  PubMed  Google Scholar 

Hibi, T., Ishibashi, T., Ikenoue, Y., Yoshihara, R., Nihei, A., & Kobayashi, T. (2020). Ulcerative colitis: Disease burden, impact on daily life, and reluctance to consult medical professionals: Results from a Japanese internet survey. Inflamm Intest Dis, 5(1), 27–35.

Article  PubMed  PubMed Central  Google Scholar 

Kim, Y. S., Jung, S. A., Lee, K. M., Park, S. J., Kim, T. O., Choi, C. H., Kim, H. G., Moon, W., Moon, C. M., Song, H. K., Na, S. Y., & Yang, S. K. (2017). Impact of inflammatory bowel disease on daily life: An online survey by the Korean Association for the Study of Intestinal Diseases. Intestinal Research, 15(3), 338–344.

Article  PubMed  PubMed Central  Google Scholar 

López-Sanromán, A., Carpio, D., Calvet, X., Romero, C., Cea-Calvo, L., Juliá, B., & Arg✓elles-Arias, F. (2017). Perceived emotional and psychological impact of ulcerative colitis on outpatients in Spain: UC-LIFE survey. Digestive Diseases and Sciences, 62(1), 207–216.

Article  PubMed  Google Scholar 

Newton, L., Randall, J. A., Hunter, T., Keith, S., Symonds, T., Secrest, R. J., Komocsar, W. J., Curtis, S. E., Abetz-Webb, L., Kappelman, M., & Naegeli, A. N. (2019). A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis. Journal of Patient-Reported Outcomes, 3(1), 66.

Article  PubMed  PubMed Central  Google Scholar 

Rapport, F., Clement, C., Seagrove, A. C., Alrubaiy, L., Hutchings, H. A., & Williams, J. G. (2019). Patient views about the impact of ulcerative colitis and its management with drug treatment and surgery: A nested qualitative study within the CONSTRUCT trial. BMC Gastroenterology, 19(1), 166.

Article  PubMed  PubMed Central  Google Scholar 

Vollebregt, P. F., van Bodegraven, A. A., Markus-de Kwaadsteniet, T. M. L., van der Horst, D., & Felt-Bersma, R. J. F. (2018). Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 47(9), 1253–1260.

Article  CAS  Google Scholar